Skip to main content
. 2018 May;17(5):416–422. doi: 10.1016/S1474-4422(18)30054-1

Table 3.

Multistate outcome analysis of treatment analysis of time to transition from one stage of amyotrophic lateral sclerosis to the next

50 mg/day riluzole 100 mg/day riluzole 200 mg/day riluzole Placebo
Stage transition
2–3 109 (99–118) 70 (60–81) 100 (89–110) 82 (72–91)
3–4 38 (29–48) 52 (43–61) 30 (23–37) 69 (61–78)
4–5 207 (195–219) 234 (222–246) 226 (215–237) 198 (186–209)

Data are the mean number of days (95% CI), presented by treatment group.